The secret to improve access to value added medicines

14 November 2019

Policy

A digital future for value added medicines

24 September 2019

Policy, Report

Positioning Statements on Physician-led Switching for Biosimilar Medicines

19 September 2019

Policy

Positioning Statements on Physician-led Switching for Biosimilar Medicines BIOSIMILAR MEDICINES […]

Open letter to the Members of the European Parliament on the importance to sustain EU progress in fighting against antimicrobial resistance (AMR)

11 September 2019

Policy

Medicines for Europe Commentary on the Draft EMA regulatory science strategy 2025

28 June 2019

Policy

Calls to action to improve access to value added medicines

26 February 2019

Policy, Report

Case Studies for Value Added Medicines. Unlocking the potential of patient-centric continuous innovation

26 February 2019

Policy, Report

Joint pharmaceutical industry statement on the Commission’s proposal for a Regulation on health technology assessment (HTA)

21 June 2018

Policy

Medicines For Europe Country Specific Market Access Policies

24 May 2018

Policy

Position paper on Best Procurement Practices

28 April 2018

Policy